Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × cediranib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Fallopian Tube Neoplasms 6 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Gliosarcoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡